Navigation Links
Global Cardiovascular Drug Delivery Technologies, Markets and Companies Report 2016-2025 - Research and Markets
Date:4/8/2016

DUBLIN, April 8, 2016 /PRNewswire/ --

Research and Markets has announced the addition of Jain PharmaBiotech's new report "Cardiovascular Drug Delivery - Technologies, Markets and Companies" to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO )

The cardiovascular drug delivery markets are estimated for the years 2015 to 2025 on the basis of epidemiology and total markets for cardiovascular therapeutics. The estimates take into consideration the anticipated advances and availability of various technologies, particularly drug delivery devices in the future. Markets for drug-eluting stents are calculated separately. Role of drug delivery in developing cardiovascular markets is defined and unmet needs in cardiovascular drug delivery technologies are identified. 

Cell-selective targeted drug delivery has emerged as one of the most significant areas of biomedical engineering research, to optimize the therapeutic efficacy of a drug by strictly localizing its pharmacological activity to a pathophysiologically relevant tissue system. These concepts have been applied to targeted drug delivery to the cardiovascular system. Devices for drug delivery to the cardiovascular system are also described. 

Role of drug delivery in various cardiovascular disorders such as myocardial ischemia, hypertension and hypercholesterolemia is discussed. Cardioprotection is also discussed. Some of the preparations and technologies are also applicable to peripheral arterial diseases. Controlled release systems are based on chronopharmacology, which deals with the effects of circadian biological rhythms on drug actions.A full chapter is devoted to drug-eluting stents as treatment for restenosis following stenting of coronary arteries.Fifteen companies are involved in drug-eluting stents. 

New cell-based therapeutic strategies are being developed in response to the shortcomings of available treatments for heart disease. Potential repair by cell grafting or mobilizing endogenous cells holds particular attraction in heart disease, where the meager capacity for cardiomyocyte proliferation likely contributes to the irreversibility of heart failure. Cell therapy approaches include attempts to reinitiate cardiomyocyte proliferation in the adult, conversion of fibroblasts to contractile myocytes, conversion of bone marrow stem cells into cardiomyocytes, and transplantation of myocytes or other cells into injured myocardium. 

Advances in molecular pathophysiology of cardiovascular diseases have brought gene therapy within the realm of possibility as a novel approach to treatment of these diseases. It is hoped that gene therapy will be less expensive and affordable because the techniques involved are simpler than those involved in cardiac bypass surgery, heart transplantation and stent implantation. Gene therapy would be a more physiologic approach to deliver vasoprotective molecules to the site of vascular lesion. Gene therapy is not only a sophisticated method of drug delivery; it may at time need drug delivery devices such as catheters for transfer of genes to various parts of the cardiovascular system.

Selected 82 companies that either develop technologies for drug delivery to the cardiovascular system or products using these technologies are profiled and 80 collaborations between companies are tabulated. The bibliography includes 200 selected references from recent literature on this topic. The report is supplemented with 30 tables and 8 figures. 

Key Topics Covered: 

0. Executive Summary

1. Cardiovascular Diseases

2. Methods for Drug Delivery to the Cardiovascular System

3. Cell Therapy for Cardiovascular Disorders

4. Gene Therapy for Cardiovascular Disorders

5. Drug-Eluting Stents

6. Markets for Cardiovascular Drug Delivery

7. Companies involved in Cardiovascular Drug Delivery

8. References 

For more information visit http://www.researchandmarkets.com/research/nrtdc8/cardiovascular 

Source: Jain PharmaBiotech


Media Contact: 
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com


For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900    


U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


'/>"/>
SOURCE Research and Markets
Copyright©2016 PR Newswire.
All rights reserved


Related medicine technology :

1. Global Laboratory and Handheld Raman Instruments Market 2016-2020 - Increased Spending on R&D -- Research and Markets
2. Global Dental Consumables Market is Expected to Expand at a CAGR of 5.7% From 2015 to 2023: Transparency Market Research
3. Global Non-Hematological Cancers Market to Hit $140.8 Billion by 2021, says GBI Research
4. Global Alzheimer Disease Report 2016 - New Drugs, Markets and Companies to 2025 Featuring 300+ Different Compounds at Various Stages of Development - Research and Markets
5. Global Nitric Oxide Therapeutics, Markets and Companies Study 2016 with Projections to 2020 & 2025 - Research and Markets
6. Global Animal Biotechnology Technologies, Markets and Companies Report 2016 - Research Activities of 11 Veterinary and Livestock Research Institutes With 108 Collaborations - Research and Markets
7. Global Gene Therapy Technologies, Markets and Companies Report 2016 - Analysis & Forecasts 2015-2025 - Research and Markets
8. Global Medication Adherence Market Expected to Grow With 17.5% CAGR During 2016-2022: P&S Market Research
9. Global Ultrasound Market Growth Steady at 5.5% CAGR to 2020
10. Global Age-Related Macular Degeneration Market Expected to Grow at 7.6% CAGR During 2016-2022: P&S Market Research
11. Global HCV Market: Gilead Sciences, AbbVie, J&J and Bristol-Myers Squibb Featured in 2016 Hepatitis C Virus Edition Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2019)... ... September 17, 2019 , ... Drs. Mario ... Medford, NJ, now welcome patients from Cherry Hill, NJ for tooth extractions, with ... whenever possible. When tooth removal is necessary, they use advanced equipment and techniques, ...
(Date:9/17/2019)... , ... September 17, 2019 , ... ... summit on sexual health, reproductive justice, contraception and consent with student and faculty ... by sexual health experts which included Francisco Ramirez, MPH; Elise Schuster, MPH; Raffaele ...
(Date:9/17/2019)... ... 2019 , ... Dr. Arta Farahmand welcomes patients with crooked ... to conventional orthodontics, the Wilckodontics orthodontic system often cuts treatment time by 50 ... brackets and wires that apply constant pressure on the teeth, thus causing the ...
Breaking Medicine Technology:
(Date:9/17/2019)... ... 17, 2019 , ... What if a drug that sits ... patients? In companion presentations at the American Society for Therapeutic Radiation Oncology (ASTRO) ... evidence that low-dose aspirin and other anti-inflammatories may improve survival in patients undergoing ...
(Date:9/17/2019)... ... September 17, 2019 , ... Specialty Technical Publishers (STP) and ... Protocol Consortium (IAPC) EHS audit protocol for Japan . Leading companies around ... EHS regulatory obligations and rapidly collect, share, archive, and export audit findings in ...
(Date:9/17/2019)... ... September 17, 2019 , ... CORE Medical & Wellness, ... (Jenny) Gartshteyn to their team of expert physicians. Dr. Gartshteyn completed her Rheumatology ... Appointment of Assistant Professor in Medicine for the Division of Hospitalist Medicine. , ...
(Date:9/14/2019)... ... , ... GreenTheVoteOk , one of the most reliable online resource providers ... most relevant and important developments in the fast-changing world of legalized CBD. , ... across the world suffering from different difficult-to-treat ailments, people need to identify brands that ...
(Date:9/11/2019)... ... September 11, 2019 , ... Workplace ... have struggled to solve injury risks which lead to musculoskeletal disorders (MSDs). ... solution developed by the team at Soter Analytics helps avoid ergonomic ...
Breaking Medicine News(10 mins):